- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/085 - Staphylococcus
Patent holdings for IPC class A61K 39/085
Total number of patents in this class: 583
10-year publication summary
|
51
|
39
|
51
|
49
|
42
|
33
|
26
|
30
|
33
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1602 |
50 |
| The University of Chicago | 1492 |
34 |
| New York University | 1844 |
19 |
| Evaxion Biotech A/S | 43 |
13 |
| The Regents of the University of California | 20790 |
12 |
| Merck Sharp & Dohme Corp. | 2183 |
12 |
| Socpra Sciences et Genie S.E.C. | 211 |
12 |
| Abvacc, Inc. | 13 |
11 |
| Novartis AG | 10224 |
9 |
| Janssen Pharmaceuticals, Inc. | 434 |
9 |
| NeoTX Therapeutics Ltd. | 15 |
9 |
| Wyeth LLC | 602 |
8 |
| MedImmune, LLC | 498 |
8 |
| Children's Medical Center Corporation | 1959 |
7 |
| The Brigham and Women's Hospital, Inc. | 2290 |
6 |
| Longhorn Vaccines and Diagnostics, LLC | 92 |
6 |
| The Texas a & M University System | 1892 |
6 |
| Xbiotech, Inc. | 66 |
6 |
| The Regents of the University of Michigan | 5002 |
5 |
| Boise State University | 125 |
5 |
| Other owners | 336 |